These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 21827578)
1. Body mass index and survival in patients with epithelial ovarian cancer. Suh DH; Kim HS; Chung HH; Kim JW; Park NH; Song YS; Kang SB J Obstet Gynaecol Res; 2012 Jan; 38(1):70-6. PubMed ID: 21827578 [TBL] [Abstract][Full Text] [Related]
2. Effect of obesity on survival in epithelial ovarian cancer. Pavelka JC; Brown RS; Karlan BY; Cass I; Leuchter RS; Lagasse LD; Li AJ Cancer; 2006 Oct; 107(7):1520-4. PubMed ID: 16941453 [TBL] [Abstract][Full Text] [Related]
3. Impact of obesity on operative morbidity and clinical outcome in primary epithelial ovarian cancer after optimal primary tumor debulking. Fotopoulou C; Richter R; Braicu EI; Kuhberg M; Feldheiser A; Schefold JC; Lichtenegger W; Sehouli J Ann Surg Oncol; 2011 Sep; 18(9):2629-37. PubMed ID: 21394662 [TBL] [Abstract][Full Text] [Related]
4. The effect of obesity on survival in patients with ovarian cancer. Matthews KS; Straughn JM; Kemper MK; Hoskins KE; Wang W; Rocconi RP Gynecol Oncol; 2009 Feb; 112(2):389-93. PubMed ID: 19062080 [TBL] [Abstract][Full Text] [Related]
5. Body mass index as a prognostic factor in epithelial ovarian cancer and correlation with clinico-pathological factors. Skírnisdóttir I; Sorbe B Acta Obstet Gynecol Scand; 2010; 89(1):101-7. PubMed ID: 19878086 [TBL] [Abstract][Full Text] [Related]
6. Effect of body mass index on mortality of patients with lymphoma undergoing autologous hematopoietic cell transplantation. Navarro WH; Loberiza FR; Bajorunaite R; van Besien K; Vose JM; Lazarus HM; Rizzo JD Biol Blood Marrow Transplant; 2006 May; 12(5):541-51. PubMed ID: 16635789 [TBL] [Abstract][Full Text] [Related]
7. Carboplatin dosing in obese women with ovarian cancer: a Gynecologic Oncology Group study. Wright JD; Tian C; Mutch DG; Herzog TJ; Nagao S; Fujiwara K; Powell MA Gynecol Oncol; 2008 Jun; 109(3):353-8. PubMed ID: 18407341 [TBL] [Abstract][Full Text] [Related]
8. Body mass index in relation to ovarian cancer survival. Zhang M; Xie X; Lee AH; Binns CW; Holman CD Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1307-10. PubMed ID: 15894691 [TBL] [Abstract][Full Text] [Related]
9. Effect of body mass index on outcomes after cardiac surgery: is there an obesity paradox? Stamou SC; Nussbaum M; Stiegel RM; Reames MK; Skipper ER; Robicsek F; Lobdell KW Ann Thorac Surg; 2011 Jan; 91(1):42-7. PubMed ID: 21172483 [TBL] [Abstract][Full Text] [Related]
10. Treatment effects, disease recurrence, and survival in obese women with early endometrial carcinoma : a Gynecologic Oncology Group study. von Gruenigen VE; Tian C; Frasure H; Waggoner S; Keys H; Barakat RR Cancer; 2006 Dec; 107(12):2786-91. PubMed ID: 17096437 [TBL] [Abstract][Full Text] [Related]
11. Hyperandrogenism, mediated by obesity and receptor polymorphisms, promotes aggressive epithelial ovarian cancer biology. Li AJ; Elmore RG; Pavelka JC; Karlan BY Gynecol Oncol; 2007 Dec; 107(3):420-3. PubMed ID: 17825390 [TBL] [Abstract][Full Text] [Related]
12. Effects of body mass index on early outcome of coronary artery bypass surgery. Shirzad M; Karimi A; Armadi SH; Marzban M; Abbasi K; Alinejad B; Moshtaghi N Minerva Chir; 2009 Feb; 64(1):17-23. PubMed ID: 19202532 [TBL] [Abstract][Full Text] [Related]
13. Is there any survival advantage of obesity in Southern European haemodialysis patients? Chazot C; Gassia JP; Di Benedetto A; Cesare S; Ponce P; Marcelli D Nephrol Dial Transplant; 2009 Sep; 24(9):2871-6. PubMed ID: 19369686 [TBL] [Abstract][Full Text] [Related]
14. Prognostic value of body mass index in Korean patients with renal cell carcinoma. Jeon HG; Jeong IG; Lee JH; Lee CJ; Kwak C; Kim HH; Lee SE; Lee E J Urol; 2010 Feb; 183(2):448-54. PubMed ID: 20006879 [TBL] [Abstract][Full Text] [Related]
15. Impact of body mass index on treatment outcomes in endometrial cancer patients receiving doxorubicin and cisplatin: a Gynecologic Oncology Group study. Modesitt SC; Tian C; Kryscio R; Thigpen JT; Randall ME; Gallion HH; Fleming GF; Gynecol Oncol; 2007 Apr; 105(1):59-65. PubMed ID: 17150247 [TBL] [Abstract][Full Text] [Related]
16. Body mass index does not affect postoperative morbidity and oncologic outcomes of total mesorectal excision for rectal adenocarcinoma. Ballian N; Yamane B; Leverson G; Harms B; Heise CP; Foley EF; Kennedy GD Ann Surg Oncol; 2010 Jun; 17(6):1606-13. PubMed ID: 20077020 [TBL] [Abstract][Full Text] [Related]
17. Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer. Dignam JJ; Polite BN; Yothers G; Raich P; Colangelo L; O'Connell MJ; Wolmark N J Natl Cancer Inst; 2006 Nov; 98(22):1647-54. PubMed ID: 17105987 [TBL] [Abstract][Full Text] [Related]
18. Elevated body mass index and intermediate-term clinical outcomes after acute coronary syndromes. Eisenstein EL; McGuire DK; Bhapkar MV; Kristinsson A; Hochman JS; Kong DF; Califf RM; Van de Werf F; Yancy WS; Newby LK Am J Med; 2005 Sep; 118(9):981-90. PubMed ID: 16164884 [TBL] [Abstract][Full Text] [Related]
19. Does body mass index affect survival of patients undergoing radical or partial cystectomy for bladder cancer? Hafron J; Mitra N; Dalbagni G; Bochner B; Herr H; Donat SM J Urol; 2005 May; 173(5):1513-7. PubMed ID: 15821470 [TBL] [Abstract][Full Text] [Related]
20. Cardiac arrest survivors with moderate elevated body mass index may have a better neurological outcome: a cohort study. Testori C; Sterz F; Losert H; Krizanac D; Haugk M; Uray T; Arrich J; Stratil P; Sodeck G Resuscitation; 2011 Jul; 82(7):869-73. PubMed ID: 21458134 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]